This phenomenon has been confirmed by another study showing that AGI-5198 confers radioprotective effects on IDH1-mutated cancer cells.65 Overall, targeting IDH-mutant neomorphic activity is a straightforward strategy and has shown efficacy against haematopoietic malignancies in humans and several experimental models for solid cancers. The gene discussed is IDH2; the disease is cancer.